🎯Investment Objective
“The fund employs a passive investment approach designed to track the performance of Nifty Pharma TRI. The fund seeks to achieve this goal by investing in securities constituting the Nifty Pharma Index in same proportion as in the Index.”
Source: Nippon India Nifty Pharma ETF scheme information document
AI Summary
indian-fundStrengths1
- Very low cost — expense ratio of 0.21%
Concerns1
- High sector concentration — Pharmaceuticals & Biotechnology accounts for 99.9% of the portfolio
Rule-based from financial data. Not advice.
Asset Allocation
Sector Allocation
Holdings-Based Style Box
This fund sits in the Mid-Blend quadrant based on its holdings characteristics.
The fund primarily holds mid-cap stocks (ranked 101–250 by market cap) — offering a balance of growth potential and relative stability. The ‘Blend’ position means the portfolio mixes both value and growth stocks — a balanced approach.
📖 What do Large/Mid/Small Cap mean? →Key Metrics
Fund DNA
Percentile ranking within ETF category (higher = better)
What does this shape tell you?
This radar shows how the fund ranks against ETF peers across 5 dimensions. A "perfect" fund would fill the entire pentagon, but that rarely exists.
This fund's strongest trait is Returns (80th percentile), it has delivered higher returns than most peers.
Its weakest area is Consistency, returns have been unpredictable. Past good years don't guarantee future ones.
Learn about risk-adjusted returns → · Why expense ratio matters →
Portfolio Holdings21 positions
The Weight column shows how much of the fund's money is in each stock. The 3M Change reveals the fund manager's recent moves, increasing weight (↑ green) means they're buying more, decreasing (↓ red) means they're trimming. Click any stock name to see its detailed financials on Equiscale.
📖 Learn: Diversification & Asset Allocation →Holdings Overlap with Your Portfolio
Investment Calculator
Estimate future value based on Nippon India Nifty Pharma ETF's historical returns
⚠️ Important Disclaimer
This projection uses past returns (22.81469912800571% CAGR) which do NOT guarantee future performance. Actual returns may vary significantly.
💡 Why SIP works: Investing ₹10,000/month uses rupee cost averaging, buying more units when markets dip. Over 5 years, this smooths out volatility.
Returns
| 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| -1.5584417974173315% | +0.5305089057788592% | +15.205148168251451% | +10.41852181656278% | +22.81469912800571% | - |
Performance
This chart shows the fund's NAV growth over time. Since inception, this fund has delivered a CAGR of 23.8%.
👤Fund Manager
Fund manager information is not available for this fund.
Similar Funds
All mutual fund data is for educational purposes only. Past performance does not guarantee future returns. Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. Equiscale does not provide investment advice.